BioCentury | Mar 8, 2019
Company News

J&J gets option to AdoRx's adenosine receptor antagonists for lung cancer

...an exclusive option to research, develop and commercialize adenosine receptor antagonists to treat lung cancer. AdoRx Therapeutics Ltd....
...partner on drug discovery and preclinical development activities. Financial details were not disclosed. Shannon Lehnbeuter, Staff Writer AdoRx Therapeutics Ltd. Johnson...
Items per page:
1 - 1 of 1
BioCentury | Mar 8, 2019
Company News

J&J gets option to AdoRx's adenosine receptor antagonists for lung cancer

...an exclusive option to research, develop and commercialize adenosine receptor antagonists to treat lung cancer. AdoRx Therapeutics Ltd....
...partner on drug discovery and preclinical development activities. Financial details were not disclosed. Shannon Lehnbeuter, Staff Writer AdoRx Therapeutics Ltd. Johnson...
Items per page:
1 - 1 of 1